Patent · US Active

Methods of producing mesoporous drug delivery implants

US8623399B2 · kind B2 · utility

8Cited by
23References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2012
Grant dateJan 7, 2014
Priority date
Expiry dateSep 12, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-erodible doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.